OR WAIT null SECS
October 17, 2023
Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the important components of nitrosamine impurities from a manufacturing point of view as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."
October 16, 2023
Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the recent findings of nitrosamine impurities in human drugs as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."
September 02, 2023
There are many promising trials in the pipeline that may bring big news for major therapeutic areas.
August 31, 2023
Twist Bioscience is a synthetic biology and genomics company that has developed a DNA synthesis platform to industrialize the engineering of biology, which is a new method of this process by “writing” DNA on a silicon chip.
August 02, 2023
The industry is taking steps to automate the final product inspection process for complex therapeutics.
July 24, 2023
WuXi STA’s new high-potency injectable line has an annual capacity of 12 million units.
July 02, 2023
Detection of nitrosamines in several commercial drugs has resulted in manufacturing batch recalls followed by a review of the APIs’ synthesis processes by MAHs.
May 17, 2023
The new method was developed to isolate tissue-specific EVs from the blood in addition to using a workflow to analyze their diverse multi-omics content.
May 16, 2023
The first CleanCap analog was launched in 2017, and since then, the capping technology has been incorporated in one of the first commercially approved COVID-19 vaccines.
May 09, 2023
According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.